-
American Medical Systems Confirms Fourth Quarter Revenue
Tuesday, February 15, 2011 - 5:21pm | 315American Medical Systems Holdings, Inc. (NASDAQ: AMMD) confirmed previously reported revenue of $147.0 million for the fourth quarter of 2010, a 0.7 percent increase over sales of $146.0 million in the comparable quarter of 2009. Adjusting for the negative impact of the stronger U.S. dollar in the...
-
Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
Tuesday, February 15, 2011 - 5:10pm | 123Gen-Probe Incorporated (NASDAQ: GPRO) today reported financial results for the fourth quarter and full year 2010, highlighted by record non-GAAP earnings per share (EPS) of $0.61 in the quarter, 17% higher than in the prior year period. "In the fourth quarter of 2010, Gen-Probe generated record...
-
Masimo Reports Q4 EPS of $0.29 vs. $0.26
Tuesday, February 15, 2011 - 5:01pm | 189Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and year ended January 1, 2011. Masimo's total revenue for the fourth quarter rose 14.0% to $105.6 million, compared to $92.6 million for the fourth quarter of 2009. Masimo's fourth quarter product revenue rose 16....
-
Dynatronics Announces $1M Stock Buyback Program
Tuesday, February 15, 2011 - 10:51am | 33Dynatronics Corporation (Nasdaq: DYNT) today announced that its board of directors has approved a $1 million open market share repurchase program of the company's common stock.
-
Trinity Biotech Announces Distribution Agreement for Premier Hb9210 Instrument
Tuesday, February 15, 2011 - 9:44am | 77Trinity Biotech plc (NASDAQ: TRIB) today announced an agreement to exclusively supply Menarini Diagnostics with the new Premier Hb9210 instrument for distribution in European territories. The Premier Hb9210 instrument is a fully automated system that measures HbA1c in high and low throughput...
-
Benzinga's Top Pre-Market Losers (NFLX, JDSU, ISRG, LLTC)
Tuesday, February 15, 2011 - 9:28am | 118Netflix Inc (NASDAQ: NFLX) dropped 2.26% to $241.85 in the pre-market session. Analysts at Morgan Stanley downgraded NFLX from “overweight” to “equal weight.” JDS Uniphase Corporation (NASDAQ: JDSU) fell 2.22% to $27.26 in the pre-market session. Analysts at Bernstein downgraded JDSU from "...
-
Morgan Keegan Maintains Outperform Rating, $60 PT On BAX
Tuesday, February 15, 2011 - 9:24am | 144Morgan Keegan is maintaining its $60 PT and Outperform rating on shares of Baxter International Inc. (NYSE: BAX). “Based on an April 2010 filing, we believe that the FDA PDUFA date for Baxter's subcutaneous 10% IgG is nearing,” Morgan Keegan writes. “Although we do not expect an FDA clearance to be...
-
Thoratec Corporation Authorizes $100M Share Repurchase Program
Monday, February 14, 2011 - 5:04pm | 38Thoratec Corporation (Nasdaq: THOR) announced today that its Board of Directors has authorized the repurchase of up to $100 million of the company's shares of common stock over the next year.
-
Cantel Medical Acquires the Sterilization Monitoring Business of ConFirm Monitoring Systems
Monday, February 14, 2011 - 11:28am | 141Cantel Medical (NYSE: CMN), through its Crosstex International subsidiary, has further expanded its infection prevention and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc. Based in Denver, Colorado. ConFirm offers both a mail-in service and...
-
Dynatronics Reports Q2 EPS of $0.01
Monday, February 14, 2011 - 11:16am | 105Dynatronics Corporation (Nasdaq: DYNT) today announced results for its fiscal second quarter ended December 31, 2010. Sales for the quarter ended December 31, 2010, were $8,199,347, compared to $8,501,437 for the quarter ended December 31, 2009. Sales for the six months ended December 31, 2010,...
-
Antares Pharma Announces Receipt of NDA User Fee Waiver
Monday, February 14, 2011 - 10:04am | 137Antares Pharma, Inc. (NYSE: AIS) today announced the receipt from the U.S. Food and Drug Administration of a waiver, on February 8, 2011, for the $1,500,000 New Drug Application filing fee for Anturol Gel for overactive bladder. The waiver, requested by Antares in accordance with section 736(d)(1...
-
Jefferies Raises HOLX Estimates
Monday, February 14, 2011 - 9:34am | 118Jefferies is making some adjustments to its Hologic (NASDAQ: HOLX) estimates. “We are increasing our F11 revenue estimate to $1,769M, from $1,750M, as well as our F11 pro-forma EPS estimate to $1.23, from $1.22. F11 consensus revenue and EPS currently stands at $1,755M and $1.23,” Jefferies writes...
-
Varian Medical Systems Announces Repurchase of Additional 12M Shares
Monday, February 14, 2011 - 9:10am | 105Varian Medical Systems, Inc. (NYSE: VAR) today announced that its Board of Directors has authorized the company to repurchase an additional 12 million shares of its common stock through the end of its fiscal year 2012. Stock repurchases may be made in the open market, in privately negotiated...
-
Biotech Investing Tips For 2011
Sunday, February 13, 2011 - 11:22am | 1138Most investors understand the volatility associated with biotech stocks. Many avoid the sector altogether, horrified at stock charts that swing over 50% within a single trading day. Massive, sudden, and (seemingly) unpredictable price movements in the shares of biotech companies have given the...
-
Fast Money Picks For February 14th (VZ, RJF, AMD, BAX, TTM)
Friday, February 11, 2011 - 9:03pm | 255On CNBC's Fast Money, Brian Kelly said that he wants to buy Advanced Micro Devices, Inc. (NYSE: AMD) on Monday. He believes that AMD's new graphic chips have potential. Advanced Micro Devices, Inc. (AMD) gained 0.73% today, and it closed at $8.28. Stephen Weiss likes Verizon Communications Inc. (...